• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测难治性支原体肺炎患儿坏死性肺炎的列线图的开发与验证

Development and validation of a nomogram for predicting necrotizing pneumonia in children with refractory Mycoplasma pneumoniae pneumonia.

作者信息

Li Xiaoying, Zhao Lihua, Cui Xiaojian, Xu Yongsheng, Zhang Tongqiang, Guo Wei, Ning Jing

机构信息

Department of Pulmonology, Tianjin Key Laboratory of Birth Defects for Prevention and Treatment, Tianjin Children's Hospital (Children's Hospital of Tianjin University, Tianjin Pediatric Research Institute, Tianjin, 300134, China.

Department of Clinical Lab, Tianjin Key Laboratory of Birth Defects for Prevention and Treatment, Tianjin Children's Hospital (Children's Hospital of Tianjin University, Tianjin Pediatric Research Institute, Tianjin, 300134, China.

出版信息

Ital J Pediatr. 2025 May 21;51(1):150. doi: 10.1186/s13052-025-02006-7.

DOI:10.1186/s13052-025-02006-7
PMID:40399899
Abstract

BACKGROUND

The early prediction of pulmonary necrosis in children with severe pneumonia improves patient prognosis and prevents complications. The aim of this study was to establish a linear model for predicting necrotizing pneumonia (NP) caused by Mycoplasma pneumoniae (MP) infection and to investigate the risk factors for lung necrosis in children with refractory Mycoplasma pneumoniae pneumonia (RMPP).

METHODS

A total of 536 children with RMPP were enrolled, including 95 with NP and 441 with nonnecrotizing pneumonia (NNP). A prediction model was built on 375 cases and validated on 161 cases, which were divided by random sampling in R software. Multivariate logistic regression was performed to determine optimal predictors and to establish a nomogram for predicting NP. The performance of the nomogram was evaluated by the area under the characteristic curve (AUC), calibration ability and decision curve analysis (DCA).

RESULTS

There were 315 (84.0%) NNP patients and 60 (16.0%) NP patients in the training group (n = 375) and 126 (78.3%) NNP patients and 35 NP patients (21.7%) in the validation group (n = 161). Multivariate logistic regression analysis identified 4 independent predictors that were used to construct a nomogram for predicting NP in children with RMPP, namely, fever duration (AOR = 1.475; 95% CI 1.296-1.678; P < 0.001), WBC count (AOR = 1.149; 95% CI 1.073-1.231; P < 0.001), IL-6 concentration (AOR = 1.007; 95% CI 1.002-1.013; P = 0.007) and D-dimer concentration (AOR = 1.361; 95% CI 1.121-1.652; P = 0.002). The area under the curve (AUC) of the nomogram was 0.899 (95% CI, 0.850-0.947) in the training set and 0.920 (95% CI, 0.874-0.966) in the validation set, indicating a good fit. The calibration plot and Hosmer‒Lemeshow test indicated that the predicted probability had good consistency with the actual probability in the training (P = 0.439) and validation (P = 0.526) groups. The DCA curve demonstrated a significantly better net fit in the model.

CONCLUSIONS

We developed and validated a nomogram model for predicting RMPP-associated NP in its early clinical stages based on fever duration, WBC count, IL-6 and D-dimer concentration. This four-risk factor model may assist physicians in predicting NP induced by RMPP.

摘要

背景

对重症肺炎儿童的肺坏死进行早期预测可改善患者预后并预防并发症。本研究的目的是建立一个预测肺炎支原体(MP)感染所致坏死性肺炎(NP)的线性模型,并探讨难治性肺炎支原体肺炎(RMPP)患儿发生肺坏死的危险因素。

方法

共纳入536例RMPP患儿,其中95例为NP,441例为非坏死性肺炎(NNP)。在R软件中通过随机抽样将375例作为构建预测模型的病例,161例作为验证病例。采用多因素logistic回归确定最佳预测指标并建立预测NP的列线图。通过特征曲线下面积(AUC)、校准能力和决策曲线分析(DCA)评估列线图的性能。

结果

训练组(n = 375)中有315例(84.0%)NNP患者和60例(16.0%)NP患者,验证组(n = 161)中有126例(78.3%)NNP患者和35例(21.7%)NP患者。多因素logistic回归分析确定了4个独立预测指标,用于构建预测RMPP患儿NP的列线图,即发热持续时间(比值比[AOR]=1.475;95%置信区间[CI]1.296 - 1.678;P < 0.001)、白细胞计数(AOR = 1.149;95% CI 1.073 - 1.231;P < 0.001)、白细胞介素-6浓度(AOR = 1.007;95% CI 1.002 - 1.013;P = 0.007)和D-二聚体浓度(AOR = 1.361;95% CI 1.121 - 1.652;P = 0.002)。列线图在训练集的曲线下面积(AUC)为0.899(95% CI,0.850 - 0.947),在验证集为0.920(95% CI,0.874 - 0.966),表明拟合良好。校准图和Hosmer-Lemeshow检验表明,预测概率与训练组(P = 0.439)和验证组(P = 0.526)的实际概率具有良好的一致性。DCA曲线显示该模型的净拟合明显更好。

结论

我们基于发热持续时间、白细胞计数、白细胞介素-6和D-二聚体浓度,开发并验证了一种用于在临床早期预测RMPP相关NP的列线图模型。这个四危险因素模型可能有助于医生预测RMPP所致NP。

相似文献

1
Development and validation of a nomogram for predicting necrotizing pneumonia in children with refractory Mycoplasma pneumoniae pneumonia.预测难治性支原体肺炎患儿坏死性肺炎的列线图的开发与验证
Ital J Pediatr. 2025 May 21;51(1):150. doi: 10.1186/s13052-025-02006-7.
2
Recognition of refractory Mycoplasma pneumoniae pneumonia among Myocoplasma pneumoniae pneumonia in hospitalized children: development and validation of a predictive nomogram model.识别住院儿童肺炎支原体肺炎中的难治性肺炎支原体肺炎:预测列线图模型的建立和验证。
BMC Pulm Med. 2023 Oct 10;23(1):383. doi: 10.1186/s12890-023-02684-1.
3
Development and validation of a nomogram to predict plastic bronchitis in children with refractory Mycoplasma pneumoniae pneumonia.开发并验证了一种列线图,用于预测难治性肺炎支原体肺炎患儿并发塑性支气管炎。
BMC Pulm Med. 2022 Jun 27;22(1):253. doi: 10.1186/s12890-022-02047-2.
4
Development and validation of a simple-to-use nomogram for predicting refractory Mycoplasma pneumoniae pneumonia in children.开发并验证一种简单易用的列线图模型,用于预测儿童难治性肺炎支原体肺炎。
Pediatr Pulmonol. 2020 Apr;55(4):968-974. doi: 10.1002/ppul.24684. Epub 2020 Feb 10.
5
Clinical features and risk factors of plastic bronchitis caused by refractory Mycoplasma pneumoniae pneumonia in children: a practical nomogram prediction model.儿童难治性肺炎支原体肺炎致塑性支气管炎的临床特征及危险因素:实用列线图预测模型。
Eur J Pediatr. 2023 Mar;182(3):1239-1249. doi: 10.1007/s00431-022-04761-9. Epub 2023 Jan 12.
6
Clinical features and risk factors analysis of bronchitis obliterans due to refractory Mycoplasma pneumoniae pneumonia in children: a nomogram prediction model.儿童难治性肺炎支原体肺炎致闭塞性细支气管炎的临床特征及危险因素分析:列线图预测模型。
BMC Infect Dis. 2021 Oct 21;21(1):1085. doi: 10.1186/s12879-021-06783-4.
7
Construction of a nomogram for early diagnosis of refractory pneumonia in children.儿童难治性肺炎早期诊断列线图的构建。
Transl Pediatr. 2024 Jul 31;13(7):1119-1129. doi: 10.21037/tp-24-16. Epub 2024 Jul 29.
8
[Risk factors for embolism in children with refractory pneumonia and construction of a nomogram model for prediction of embolism].[难治性肺炎患儿发生栓塞的危险因素及预测栓塞的列线图模型构建]
Zhongguo Dang Dai Er Ke Za Zhi. 2024 May 15;26(5):486-492. doi: 10.7499/j.issn.1008-8830.2311146.
9
Development and validation of an online dynamic nomogram system for pulmonary consolidation in children with Mycoplasma pneumoniae pneumonia.开发和验证一种用于肺炎支原体肺炎患儿肺部实变的在线动态列线图系统。
Eur J Clin Microbiol Infect Dis. 2024 Jun;43(6):1231-1239. doi: 10.1007/s10096-024-04834-7. Epub 2024 Apr 24.
10
Development of a Nomogram for Predicting Refractory Pneumonia in Children.儿童难治性肺炎预测列线图的开发
Front Pediatr. 2022 Feb 25;10:813614. doi: 10.3389/fped.2022.813614. eCollection 2022.

本文引用的文献

1
Risk Prediction Model for Necrotizing Pneumonia in Children with Pneumonia.儿童肺炎坏死性肺炎的风险预测模型
J Inflamm Res. 2023 May 15;16:2079-2087. doi: 10.2147/JIR.S413161. eCollection 2023.
2
[Analysis of clinical features and risk factors of necrotizing pneumonia in children].[儿童坏死性肺炎的临床特征及危险因素分析]
Beijing Da Xue Xue Bao Yi Xue Ban. 2022 Jun 18;54(3):541-547. doi: 10.19723/j.issn.1671-167X.2022.03.021.
3
Mycoplasma pneumoniae-induced rash and mucositis: A new entity.肺炎支原体感染相关性皮疹和黏膜炎:一种新的综合征。
Indian J Dermatol Venereol Leprol. 2022 May-Jun;88(3):349-353. doi: 10.25259/IJDVL_660_19.
4
Early prediction of necrotizing pneumonia from mycoplasma pneumoniae pneumonia with large pulmonary lesions in children.儿童大环内酯类耐药肺炎支原体肺炎大病灶时早期预测坏死性肺炎。
Sci Rep. 2020 Nov 4;10(1):19061. doi: 10.1038/s41598-020-76083-5.
5
The clinical characteristics and risk factors for necrotizing pneumonia caused by Mycoplasma pneumoniae in children.儿童肺炎支原体所致坏死性肺炎的临床特征及危险因素。
BMC Infect Dis. 2020 Jun 1;20(1):391. doi: 10.1186/s12879-020-05110-7.
6
D-dimer as A Biomarker of Severity and Adverse Outcomes in Patients with Community Acquired Pneumonia.D-二聚体作为社区获得性肺炎患者严重程度和不良预后的生物标志物。
Arch Med Res. 2020 Jul;51(5):429-435. doi: 10.1016/j.arcmed.2020.04.014. Epub 2020 Apr 24.
7
Comparison of a novel chemiluminescence immunoassay with the passive agglutination method for the diagnosis of Mycoplasma pneumoniae infection in children.比较新型化学发光免疫分析法与被动凝集法在儿童肺炎支原体感染诊断中的应用。
J Microbiol Methods. 2020 Jun;173:105921. doi: 10.1016/j.mimet.2020.105921. Epub 2020 Apr 19.
8
Critical combination of initial markers for predicting refractory Mycoplasma pneumoniae pneumonia in children: a case control study.预测儿童难治性肺炎支原体肺炎的初始标志物临界组合:病例对照研究。
Respir Res. 2019 Aug 23;20(1):193. doi: 10.1186/s12931-019-1152-5.
9
Necrotizing pneumonia caused by refractory Mycoplasma pneumonia pneumonia in children.儿童难治性肺炎支原体肺炎致坏死性肺炎。
World J Pediatr. 2018 Aug;14(4):344-349. doi: 10.1007/s12519-018-0162-6. Epub 2018 Jun 11.
10
Mycoplasma pneumoniae Among Children Hospitalized With Community-acquired Pneumonia.肺炎支原体在儿童社区获得性肺炎住院患者中的分布。
Clin Infect Dis. 2019 Jan 1;68(1):5-12. doi: 10.1093/cid/ciy419.